The Czech Republic, long considered one of Europe’s most progressive countries on cannabis and wider drug reform, is entering a period of political transition following its parliamentary election earlier this month.
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
An amendment that would see a full commercial adult-use cannabis market established in the Czech Republic has finally been brought to the government after months of waiting.
Thousands more doctors in the Czech Republic will soon be permitted to prescribe medical cannabis under a new decree published by the Ministry of Health.
As the Czech Republic’s efforts to launch a fully regulated adult-use cannabis market continue to hang in the balance, numerous efforts to convince government ministers and the general public that it would be beneficial for the country have now been launched.
The Czech Republic’s cannabis legalisation project remains stuck in political and legislative limbo, as the rumour mill surrounding its future moves into overdrive.
The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business of Cannabis.
Earlier this week, the Czech Government announced that the driving force behind its pioneering cannabis legalisation project, Jindřich Vobořil, will be stepping down in August.
The sunny second day of Cannabis Europa 2024 followed a lively evening at the inaugural Business of Cannabis Awards, where Curaleaf, Hannah Deacon, Cannavigia, Medicann and Cannareporter, among many others, were recognised for their contributions to the industry.
